Cardiovascular Function and Treatment in Beta-Thalassemia Major

Updated:Jun 18,2013
Science News-Banner_HeaderPON_ScienceNews_DiscussThis

Cardiovascular Function and Treatment in Beta-Thalassemia Major


Circ Journal Cover for Science News

  • Heart failure (HF) is  the most common cause of death in Thalassemia Major.
  • In patients with Beta-thalassemia Major, acute and chronic forms of heart failure require different treatment.
  • Life expectancy is extended with use of chelation therapy.


    Read the full article in Circulation
    Circulation. 2013: published online before print June 17, 2013, 10.1161/CIR.0b013e31821c7c64.

Science-News-Supporting-Materials_Header Science-News-Other-Resources-Header
Science News-Related-Science_Header 

Did you see these recent Commentaries?

Commentaries View All


Connect with AHA Science News

Follow AHAScience on Twitter (opens in new window)
Like AHA Science News on Facebook (opens in new window)

Network with over 31,000 Heart and Stroke Professionals

  • Connect with others around the world
  • Share and discuss articles by prominent heart and stroke researchers
     
    Join the AHA's Professional Online Network at networking.americanheart.org    Login to AHA's Professional Online Network at networking.americanheart.org